Emma Walmsley, the first woman to run a major pharmaceutical company, is making sweeping changes at GlaxoSmithKline, replacing nearly half the company’s top 125 executives and shutting down two dozen clinical trials.
from WSJ.com: US Business https://ift.tt/2GrQLpu
via IFTTT
No comments:
Post a Comment